Data-Mining for Sulfur and Fluorine: An Evaluation of Pharmaceuticals To Reveal Opportunities for Drug Design and Discovery

Oct 10, 2013Journal of medicinal chemistry

Using data analysis of sulfur and fluorine in medicines to find new drug design opportunities

AI simplified

Abstract

A total of 1969 drugs were analyzed to explore the role of sulfur and fluorine in pharmaceuticals over the past 50 years.

  • Sulfur and fluorine are significant components in the composition of pharmaceuticals.
  • Trends were examined across 12 disease categories using a graphical montage of drug information.
  • The analysis highlights the structural diversity and evolution of sulfur in drug development.
  • Fluorine has been increasingly integrated into pharmaceuticals during the last five decades.
  • The findings aim to inspire new ideas in the field of drug development.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free